Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
5701
Stride-to-stride fluctuations for the ankle were significantly decreased for the sound leg compared to the prosthetic leg.
Published 2014“…Through the adaptation, a significant U-shaped quadratic trend was present, with significantly increased stride-to-stride fluctuations at the initial visit and final visit compared to the middle of the adaptation period. (mean ± SEM) SL: sound leg; PL: prosthetic leg; MA: “more appropriate” prosthesis; LA: “less appropriate” prosthesis; V1: initial visit; V2: second visit; V3: final visit. …”
-
5702
-
5703
Antagonism of miR-21 reversed EMT phenotype, as well as decreased cell migration and invasion.
Published 2013“…<p>MDA-MB-231 cells were transfected with hsa-miR-21 antagomir or hsa-miR-21 antagomir control at a final concentration of 50 nmol for 48 h. (A) MDA-MB-231 cells were treated with hsa-miR-21 antagomir decreased the expression of miR-21, as compared to control groups (n1 = n2 = 3; p = 0.0015), by real-time RT-PCR analysis. …”
-
5704
-
5705
-
5706
-
5707
-
5708
Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice
Published 2011“…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”
-
5709
-
5710
-
5711
-
5712
-
5713
-
5714
-
5715
Effects of vidarabine, V2E, V3E and V5E on AC activity in the heart of WT and AC5KO mice.
Published 2025“…<p>(A) Vidarabine (Vida), V2E, V3E and V5E similarly and significantly decreased ISO (50 µmol/L)-stimulated AC activity in the WT heart in a dose-dependent manner. …”
-
5716
-
5717
-
5718
-
5719
-
5720